Breakthrough Gene Therapy at Primary Childrenâs Hospital helps little cowboy thrive
A rare, progressive genetic disease thatâs often fatal for infants and toddlers has been stopped its tracks by a groundbreaking gene therapy at Intermountain Primary Childrenâs Hospital.
By: Sponsored Content
and last updated 2021-02-11 10:35:47-05
A rare, progressive genetic disease thatâs often fatal for infants and toddlers has been stopped its tracks by a groundbreaking gene therapy at Intermountain Primary Childrenâs Hospital.
Primary Childrenâs was one of the first in the United States to offer the gene therapy Zolgensma, used to treat spinal muscular atrophy (SMA) in children younger than 2 years.